Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The automatic implantable cardioverter-defibrillator: an overview.

M Mirowski

    Journal of the American College of Cardiology
    |August 1, 1985
    PubMed
    Summary

    The automatic implantable cardioverter-defibrillator (AICD) effectively treats life-threatening ventricular arrhythmias. This device significantly improves survival rates in high-risk patients by reliably correcting abnormal heart rhythms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is the ABCB1 gene associated with the increased risk of gastric cancer development?--preliminary research.

    Pathology, research and practice·2014
    Same author

    Quantitative analysis of the p65 gene expression in patients with coloroctal cancer.

    International journal of biomedical science : IJBS·2013
    Same author

    Influence of antibiotic therapy on the level of selected angiogenic factors in patients with benign gynecologic tumors--preliminary report.

    Die Pharmazie·2011
    Same author

    Release kinetics of basic fibroblast growth factor (bFGF) from certain biopolymers in the presence of ketoprofen.

    Die Pharmazie·2010
    Same author

    Targeted delivery of anti-cancer growth inhibitory peptides derived from human alpha-fetoprotein: review of an International Multi-Center Collaborative Study.

    Journal of drug targeting·2010
    Same author

    Maspin and Nm23-H1 expression in colorectal cancer.

    Neoplasma·2010

    Area of Science:

    • Cardiology
    • Biomedical Engineering
    • Medical Devices

    Background:

    • Malignant ventricular tachyarrhythmias pose a significant risk to patient survival.
    • Existing treatments for these conditions can be invasive or have limited efficacy.

    Purpose of the Study:

    • To evaluate the clinical effectiveness and safety of the automatic implantable cardioverter-defibrillator (AICD).
    • To assess the impact of AICD implantation on survival rates in patients with recurrent, refractory ventricular tachyarrhythmias.

    Main Methods:

    • Continuous cardiac monitoring and identification of ventricular tachyarrhythmias.
    • Delivery of electrical countershock for rhythm restoration.
    • Implantation of AICD in nearly 500 patients with follow-up up to 59 months.

    Main Results:

    • The AICD reliably identified and corrected potentially lethal ventricular tachyarrhythmias.
    • Risks and complications associated with the device were found to be moderate.
    • Actuarial analysis showed a significant improvement in survival, with a 1-year arrhythmic mortality rate reduced to 2% or less.

    Conclusions:

    • The automatic implantable cardioverter-defibrillator offers a substantial improvement in survival for properly selected high-risk patients.
    • AICD therapy is a reliable method for managing life-threatening ventricular tachyarrhythmias.

    Related Experiment Videos